JOIN US FOR A FREE SEMINAR! Click to hear more about seminar series Upcoming Seminars Canfield Ohio Tuesday October 5th 7:00 PM Akron Ohio Tuesday October 12th 7:00 PM Leos's Ristorante Niles Ohio Thursday October 14th 7:00 PM Cleveland Racquet Club Pepper Pike Ohio Tuesday October 19th 7:00 PM Dr. Gentile Speaking Engagements 33rd Annual Meeting of the European Academy of Facial Plastic Surgery September 1-5, 2010. Antalya/Turkey American Academy of Facial Plastic & Reconstructive Surgery Annual Meeting September 23-25, 2010 Boston, MA, USA The 1st World Congress on Controversies in Plastic Surgery & Dermatology (CoPLASDy) November 4-7, 2010 Barcelona, Spain Rejuvenation of the Aging Face January 19-23, 2011 San Diego, California Munich Facial Plastic Surgery 2011 February 14-18, 2011 Munich Germany

For more information: Linda Giangardella 330-758-2001 www.facialplastics.org

The FDA has approved Dysport to treat forehead wrinkles and frown lines, making it only the second drug to be approved by the agency as a wrinkle treatment.

Dysport (formerly known as Reloxin) is made from the same active ingredient as Botox (made by Allergan), Clostridium botulinim toxin type A. Botulinum toxins temporarily reduce the appearance of wrinkles by restricting the muscle actions that cause creasing and frown lines.

Like Botox, Dysport is administered via an injection at the site of forehead wrinkles. The FDA based its approval on clinical trials involving about 2,900 people at 80 study sites. Dysport has been used in Europe since the early 90’s
One clinical trial showed 93%-95% of participants noticed an improvement in the appearance of forehead wrinkles within seven days after treatment, and multiple treatments produced effects that lasted for more than 13 months.

The most common side effects of Dysport are nose and throat irritation, headache, pain and skin reaction at the injection site, upper respiratory tract infection, eyelid swelling or drooping, sinus inflammation, and nausea.